Cellosaurus cell line Ma-10 (CVCL_7061)

• Mutation; HGNC; 11998; TP53; Simple; p.Gly245Val (c.734G>T); ClinVar=VCV000376603; Zygosity=Unspecified (PubMed=20557307).
  

PubMed=1650680; DOI=10.1378/chest.100.2.429
Masuda N., Fukuoka M., Takada M., Kudoh S., Kusunoki Y.
Establishment and characterization of 20 human non-small cell lung cancer cell lines in a serum-free defined medium (ACL-4).
Chest 100:429-438(1991)

PubMed=9393586; DOI=10.1007/s004320050101
Shimizu E., Zhao M.-R., Shinohara A., Namikawa O., Ogura T., Masuda N., Takada M., Fukuoka M., Sone S.
Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell lines.
J. Cancer Res. Clin. Oncol. 123:533-538(1997)

PubMed=11005564; DOI=10.1038/sj.neo.7900094
Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M., Yokota J.
Mutation and expression of the DCC gene in human lung cancer.
Neoplasia 2:300-305(2000)

PubMed=15802814; DOI=10.1248/bpb.28.707
Ikuta K., Takemura K., Sasaki K., Kihara M., Nishimura M., Ueda N., Naito S., Lee E., Shimizu E., Yamauchi A.
Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells.
Biol. Pharm. Bull. 28:707-712(2005)

PubMed=19472407; DOI=10.1002/humu.21028
Blanco R., Iwakawa R., Tang M.-Y., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.
A gene-alteration profile of human lung cancer cell lines.
Hum. Mutat. 30:1199-1206(2009)

PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x
Iwakawa R., Kohno T., Enari M., Kiyono T., Yokota J.
Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.
Cancer Sci. 101:1891-1896(2010)

PubMed=22313637; DOI=10.4161/cbt.19238
Takata M., Chikumi H., Miyake N., Adachi K., Kanamori Y., Yamasaki A., Igishi T., Burioka N., Nanba E., Shimizu E.
Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.
Cancer Biol. Ther. 13:369-378(2012)